Flagship Pioneering is an American life sciences venture capital company based in Cambridge, Massachusetts that invests in biotechnology, life sciences, health and sustainability companies. From Wikipedia
The agreements aim to develop new treatments for obesity and metabolic dysfunction-associated steatohepatitis, boosting Novo Nordisk's shares to a record high.
